CKD is under-recognized and undertreated in offices of primary care physicians (PCPs) despite the Kidney Disease Outcomes Quality Initiative clinical practice guidelines and the more recent Kidney Disease Improving Global Outcomes guidelines (1-3). As a result of competing demands, the PCP has inadequate time to complete all of the evidence-based preventative services and interventions for chronic disease management (4-6). The promise of the electronic medical record (EMR) to promote efficiencies in population health and chronic disease management has not yet been realized. Therefore, any steps that help the PCP or office staff be more efficient in the care of chronic complex comorbid conditions, such as CKD, are welcome. Importantly, the design of decision-support tools to integrate into routine PCP and staff workflows is essential for the successful implementation.Mendu et al. evaluated adherence to an evidencebased CKD computer decision-support checklist in 105 patients treated by four PCPs compared with usual care in 263 patients of nine control PCPs at a single site (7). After being populated with relevant laboratory and clinical parameters unique to the patient, the checklist was e-mailed to the intervention PCP in advance of the outpatient visit as well as incorporated into the EMR for review, annotation, and maintenance in the EMR as a separate note from the visit documentation. After 1 year, the EMR registry revealed that the intervention resulted in both clinically and statistically significant changes in CKD care versus controls in a number of measures including increased use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers from 48.7% to 67.6% (P,0.001), documentation of a discussion regarding avoidance of nonsteroidal anti-inflammatory drugs, increased vaccination for influenza and pneumococcus, and improved hemoglobin A1C levels. In addition, process measures were improved for appropriate laboratory testing for albuminuria, serum phosphorus, and parathyroid hormone. There was no change in achievement of BP or cholesterol targets. One of the strengths of this study is attention to the clinician's workflow, using the checklist to create a priority so that CKD was treated appropriately. This is a step above a simple alert at the point of care. PCPs are now suffering from "alert fatigue" from too many pop-ups and alerts occurring (5). Therefore, both the tool and its incorporation into the workflow that are important in making these kinds of projects successful.Although the study by Mendu et al. is not a randomized controlled trial, it is important quality improvement (QI) research. QI research evaluates a QI intervention group versus a comparison group, using scientific rigor. Another strength of the article by Mendu et al. is that the analysis considered confounding variables such as historical performance in implementing evidence-based guidelines and contemporary performance for other measures that were not part of the checklist (7). The extra time and attention necessary ...